---
document_datetime: 2023-09-21 21:43:59
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/steps-after-cutoff/kogenate-bayer-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
document_name: kogenate-bayer-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
version: success
processing_time: 1.1468964
conversion_datetime: 2025-12-23 23:57:26.783512
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## STEPS TAKEN AFTER GRANTING THE MARKETING AUTHORISATION

For procedures finalised after 1 January  2003 please refer to module 8B

- The MAH in accordance with Commission Regulation (EC) No. 542/95, as amended, submitted an application for a Type I variation that referred to the addition of an alternative packaging site. A notification was issued on 12 October 2000.
- The Manufacturing Authorisation Holder (MAH), in accordance with Commission Regulation (EC)  No.  542/95,  as  amended,  submitted  an  application  for  a  Type  II  variation  procedure regarding the update of the Plasma Master File. A positive opinion was adopted by the CPMP on 19 October 2000.

| Scope                                                              | Application number   | Type of modification 1   | Notification/ Opinion issued on 2   | Commission Decision Issued/amen ded on   |
|--------------------------------------------------------------------|----------------------|--------------------------|-------------------------------------|------------------------------------------|
| Quality changes Alternative fermenter size                         | II/0001              | II                       | 16.11.00                            | 23.11.00                                 |
| Alternative packaging site                                         | I/0003               | I                        | 12.10.00                            | 20.12.00                                 |
| Demonstration of TSE compliance                                    | II/0004              | II                       | 28.05.02                            | 05.06.02                                 |
| Change in storage conditions                                       | I/0006               | I                        | 13.08.01                            | 24.10.01                                 |
| Plasma Master File Update                                          | II/0007              | II                       | 13.12.01                            | 17.12.01                                 |
| Change of batch size and freeze-drying cycle                       | I/0008               | I                        | 24.04.02                            | 30.04.02                                 |
| Update of the SPC (point 4.8) following 2nd PSUR                   | II/0009 longer       | II                       | 19.09.02                            | 05.12.02                                 |
| Change in specifications and action limits for In-process controls | II/0010              | II                       | 19.09.02                            | 25.09.02                                 |
| Plasma master file update 2002                                     | II/0011              | II                       | 17.10.02                            | 23.10.02                                 |

Subsequent post Marketing Authorisation applications agreed upon are summarised in the table below: Scope Quality changes Alternative fermenter size Alternative packaging site Demonstration of TSE compliance Change in storage conditions Plasma Master File Update Change of batch size and freeze-drying cycle Update of the SPC (point 4.8) following 2nd PSUR Change in specifications and action limits for In-process controls Plasma master file update 2002 Medicinal product no longer authorised

1 In accordance with Commission Regulation (EC) No. 542/95 of 10 March 1995, as amended: I refers to a minor variation (Type I variation); II refers to a major variation (Type II variation); I/II refers to a minor variation following the procedure set out in Article 6, 7 and 8 of the Regulation; X refers to an Annex II application.

T refers to a transfer of a Marketing Authorisation in accordance with Commission Regulation (EC) No 2141/96 of 7 November 1996.

N refers to a notification in accordance with Article 10(3) of Council Directive 92/27/EEC of 31 March 1992.

2 For Notifications and Type I variations, the date of entry into force of the change is the EMEA Notification date. The Commission Decision will be amended accordingly.